Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam ED50 for Anesthesia Induction in Frail Elderly Patients
NCT07467603Completed
- Sponsor
- The First Hospital of Hebei Medical University
- Start
- Feb 2025
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of remimazolam in anesthesia induction (2 arms), sponsored by The First Hospital of Hebei Medical University. Primary endpoint: Sedation Success (Loss of Consciousness) up to 2 minutes. Started Feb 2025; status: completed.
02
Drugs
remimazolam
03
Conditions
anesthesia induction
Beyond the preview
Go deeper on NCT07467603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07467603.